Olaris

Curated by Signal

Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration

Overview

Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration. It offers high-throughput metabolomics and machine learning platform that identifies metabolite signatures for precision medicine.

Key facts

Founded: 2014
Headquarters: Waltham, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Atapir
Developer of a medical device for anesthesia delivery
Life Sciences TechnologySan Rafael, United States
OmicsCraft
Developer of computational tools and algorithms for omics data analysis
Life Sciences TechnologyWashington, United States
Altimate
Provider of medical devices for neurological disease, and computational physics
Life Sciences TechnologyBoston, United States

About Olaris

What does Olaris do?

Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration.

Where is Olaris headquartered?

Olaris is headquartered in Waltham, United States.

When was Olaris founded?

Olaris was founded in 2014.

Which sector is Olaris in?

Olaris operates in Life Sciences Technology.

Who are Olaris's competitors?

Companies similar to Olaris include Atapir, OmicsCraft, and Altimate.